Modular Medical Inc
For the period ended Mar 31, 2024. Filed Jun 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jun 21, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 21 st day of June, 2024.
| MODULAR MEDICAL, INC. | |
| By: | /s/ James E. Besser |
| James E. Besser | |
| Chief Executive Officer, | |
| (Principal Executive Officer) |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints James E. Besser and Paul DiPerna as her/his true and lawful attorneys-in-fact and agent, with full power of substitution and resubstitution, for her and him and in her or his name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in- fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ James E. Besser | Chief Executive Officer | June 21, 2024 |
| James E. Besser | (Principal Executive Officer) | |
| /s/ Paul DiPerna | Chairman, President and Chief Financial Officer (Principal Financial and Accounting Officer) | June 21, 2024 |
| Paul DiPerna | ||
| /s/ Duane DeSisto | Director | June 21, 2024 |
| Duane DeSisto | ||
| /s/ Steven Felsher | Director | June 21, 2024 |
| Steven Felsher | ||
| /s/ Morgan C. Frank | Director | June 21, 2024 |
| Morgan C. Frank | ||
| /s/ Philip Sheibley | Director | June 21, 2024 |
| Philip Sheibley | ||
| /s/ Carmen Volkart | Director | June 21, 2024 |
| Carmen Volkart | ||
| /s/ Ellen O’Connor Vos | Director | June 21, 2024 |
| Ellen O’Connor Vos | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.